Oxford BioDynamics (OBD) Share Price, News & Analysis

Company Overview

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

Key Stats

• Today's Range: 1.16 to 1.28
• 50-Day Range: 1.12 to 3.88
• 52-Week Range: 0.97 to 36.90
• Volume: 541,204 shs
• Average Volume: 1.83 million shs
• Market Capitalization: £3.60 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OBD Stock Analysis - Frequently Asked Questions

How have OBD shares performed this year?

Oxford BioDynamics' stock was trading at GBX 28 on January 1st, 2024. Since then, OBD shares have decreased by 95.7% and is now trading at GBX 1.21.
View the best growth stocks for 2024 here.

How were Oxford BioDynamics' earnings last quarter?

Oxford BioDynamics Plc (LON:OBD) issued its quarterly earnings results on Tuesday, June, 16th. The biotechnology company reported ($2.20) earnings per share (EPS) for the quarter.

How do I buy shares of Oxford BioDynamics?

Shares of OBD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Oxford BioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford BioDynamics investors own include 4D pharma (DDDD), B&M European Value Retail (BME), BP (BP), Coats Group (COA), genedrive (GDR), Greencore Group (GNC) and Intel (INTC).

Company Calendar

• Last Earnings: 6/16/2020
• Today: 11/24/2024

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:OBD
• CUSIP: N/A
• CIK: N/A
• Web: www.oxfordbiodynamics.com
• Phone: +44-1865-518910
• Fax: N/A
• Employees: 45
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-11,110,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -266.70%
• Return on Assets: -56.23%

Debt

• Debt-to-Equity Ratio: 370.22
• Current Ratio: 0.68
• Quick Ratio: 2.80

Sales & Book Value

• Annual Sales: £176,000.00
• Price / Sales: 21.35
• Cash Flow: GBX 0.30 per share
• Price / Cash Flow: 3.98
• Book Value: GBX 1 per share
• Price / Book: 1.21

Miscellaneous

• Outstanding Shares: 311,860,000
• Free Float: N/A
• Market Cap: £3.76 million
• Optionable: Not Optionable
• Beta: 0.42